KOSDAQ large cap
Sam Chun Dang Pharm.
A pharma company strong in eye drops, pursuing ophthalmic medicines, biosimilars and oral insulin development. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
000250.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-07-10'21-43%'22+40%'23+33.3%'24+187.4%'25+161.2%YTD-58.5%
Money in ▸·
Sam Chun Dang Pharm.
▸ Money out·
Financials & Segments
- Segments · Eye drops/prescription drugs · Biosimilars · Oral insulin
Revenue from
No refined links yet.
Pays to
No refined links yet.